检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《有机化学》2015年第2期337-361,共25页Chinese Journal of Organic Chemistry
基 金:广东省引进创新创业团队计划(No.201301Y0105381261)资助项目~~
摘 要:论述了现代有机合成化学在一些创新药物尤其是"重磅炸弹"新药,如索非布韦(Sofosbuvir)、利伐沙班(Rivaroxaban)、恩杂鲁胺(Enzalutamide)、卡格列净(Canagliflozin)和托法替尼(Tofacitinib),研发中的应用和进展,突出显示了催化过程、闭环复分解反应、钯催化的交叉偶联、绿色化学和叠缩工艺等合成方法.通过数十个新分子实体药物发明历程的回顾,诠释了现代有机合成在新药开发中的重要作用.This article reviews the application and progress of modern synthetic methods to deliver several innovative drugs, especially the blockbusters, such as sofosbuvir, rivaroxaban, enzalutamide, canagliflozin and tofacitinib. Some of the modern synthetic methods, for example catalytic processes, application of ring-closing metathesis, palladium catalyzed cross-coupling, green chemistry and telescoping of processes, are highlighted. The exciting journey from discovering these new molecular entities, especially those which are first-in-class with the synthesis of a dozen of approved drugs, is described as case studies to fully illustrate the important role of modern organic synthesis for successful drug discovery and development.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3